Q linea AB

Q linea AB has a market price of 18.2 SEK and a market capitalization of 344,867,286.4 SEK. The company's price-to-book ratio is 5.06, and its price-to-tangible-book ratio is also 5.06. The enterprise value to EBITDA ratio is -5.83, indicating a negative EBITDA, and the enterprise value to revenue ratio is 2,396.18. The company's liquidity position is assessed as medium, with a current ratio of 1.19 and negative net cash after subtracting total debt.

The company's profitability metrics are negative, with a return on equity of -0.9657 and a return on assets of -0.4137. The debt-to-equity ratio is 0.84, suggesting a moderate level of leverage. The operating cash flow is -92,088,000 SEK, and the free cash flow is -65,343,000 SEK, indicating significant cash outflows.

Q linea AB's revenue is 159,000,000 SEK, and its gross profit is -27,300,000 SEK. The operating income is -65,374,000 SEK, and the net income is -65,774,000 SEK, showing substantial losses. The capital expenditure is -6,519,000 SEK, indicating ongoing investment in capital assets.

The company's growth trajectory is uncertain, with a mean revenue estimate of 107,000,000 SEK and a mean EBIT estimate of -99,000,000 SEK. The last actual revenue was 11,098,000 SEK, and the last actual EPS was -27.40 SEK. The mean price target is 50.00 SEK, significantly higher than the current market price.

The risk assessment indicates a medium liquidity risk and a low dilution risk. The key financial flag is the negative net cash after subtracting total debt, which could impact the company's ability to meet short-term obligations.

Recent financial observations show that the company is experiencing significant financial challenges, with negative operating and net income, and a high price-to-revenue ratio. The company's financial health is a concern, and it may need to address its cash flow and profitability issues to sustain operations.

Analysts project a 201% upside to a target price of 50.0 SEK, significantly above the current market price of 16.6 SEK.

Revenue surged 369.9% year-over-year to 11.1 million SEK in FY2026, indicating strong top-line growth momentum.

Net losses improved by 15.9% year-over-year to -182.5 million SEK in FY2026, showing a trajectory toward reduced deficits.

Free cash flow losses narrowed by 13.0% year-over-year to -177.5 million SEK in FY2026, suggesting improving cash generation efficiency.

Cash conversion ratio of 1.4 ranks in the top quartile of the Advanced Medical Equipment cohort, outperforming the median of 0.79.

The company posted a net loss of 182.5 million SEK in FY2026, resulting in a negative net margin of -413.7%.

Operating margin of -411.2% places the company in the bottom quartile of the 196-company Advanced Medical Equipment cohort.

Debt-to-equity ratio of 0.84 is in the bottom quartile, far exceeding the cohort median of 0.06.

The company faces medium liquidity risk, which could constrain operations given its persistent negative free cash flow.

Revenue kr 2.0M, −45,0% YoY; Operating income +21,5% YoY.

• ▍Revenue kr 2.0M, −45,0% YoY
• ▍Operating income +21,5% YoY
• ▍Net income +25,8% YoY
• ▍Free cash flow +22,3% YoY
• ▍Net margin -1658.3%

Revenue kr 2.9M, +1 710,8% YoY; Operating income +14,0% YoY.

• ▍Revenue kr 2.9M, +1 710,8% YoY
• ▍Operating income +14,0% YoY
• ▍Net income +11,2% YoY
• ▍Free cash flow +5,6% YoY
• ▍Net margin -1639.6%

Revenue kr 3.5M, +510,4% YoY; Operating income +1,1% YoY.

• ▍Revenue kr 3.5M, +510,4% YoY
• ▍Operating income +1,1% YoY
• ▍Net income +0,4% YoY
• ▍Free cash flow −12,2% YoY
• ▍Net margin -1214.9%

Revenue kr 1.1M, +581,1% YoY; Operating income +27,6% YoY.

• ▍Revenue kr 1.1M, +581,1% YoY
• ▍Operating income +27,6% YoY
• ▍Net income +26,8% YoY
• ▍Free cash flow +24,5% YoY
• ▍Net margin -4446.1%

Revenue kr 3.7M; Operating income -kr 44.6M.

• ▍Revenue kr 3.7M
• ▍Operating income -kr 44.6M
• ▍Net margin -1228.8%

Revenue kr 158.0k; Operating income -kr 51.2M.

• ▍Revenue kr 158.0k
• ▍Operating income -kr 51.2M
• ▍Net margin -33415.2%

Revenue kr 569.0k; Operating income -kr 41.1M.

• ▍Revenue kr 569.0k
• ▍Operating income -kr 41.1M
• ▍Net margin -7445.7%

Revenue kr 159.0k; Operating income -kr 65.4M.

• ▍Revenue kr 159.0k
• ▍Operating income -kr 65.4M
• ▍Net margin -41367.3%

Revenue kr 11.1M, +369,9% YoY; Operating income +17,3% YoY.

• ▍Revenue kr 11.1M, +369,9% YoY
• ▍Operating income +17,3% YoY
• ▍Net income +15,9% YoY
• ▍Free cash flow +13,0% YoY
• ▍Net margin -1644.3%

Revenue kr 2.4M, −46,8% YoY; Operating income +7,3% YoY.

• ▍Revenue kr 2.4M, −46,8% YoY
• ▍Operating income +7,3% YoY
• ▍Net income +5,5% YoY
• ▍Free cash flow +7,3% YoY
• ▍Net margin -9181.7%

Revenue kr 4.4M, −65,3% YoY; Operating income +12,1% YoY.

• ▍Revenue kr 4.4M, −65,3% YoY
• ▍Operating income +12,1% YoY
• ▍Net income +14,6% YoY
• ▍Free cash flow +22,1% YoY
• ▍Net margin -5165.9%

Revenue kr 12.8M, +37,0% YoY; Operating income −13,0% YoY.

• ▍Revenue kr 12.8M, +37,0% YoY
• ▍Operating income −13,0% YoY
• ▍Net income −16,1% YoY
• ▍Free cash flow +35,1% YoY
• ▍Net margin -2101.1%